[HTML][HTML] Bronchopulmonary dysplasia

B Thébaud, KN Goss, M Laughon, JA Whitsett… - Nature reviews Disease …, 2019 - nature.com
In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants

LW Doyle, JL Cheong, S Hay… - Cochrane Database …, 2021 - cochranelibrary.com
Background Bronchopulmonary dysplasia (BPD) remains a major problem for infants born
extremely preterm. Persistent inflammation in the lungs is important in its pathogenesis …

Bronchopulmonary dysplasia: executive summary of a workshop

RD Higgins, AH Jobe, M Koso-Thomas… - The Journal of …, 2018 - jpeds.com
300 increased to< 90%. 7, 8 More recently, the Canadian Neonatal Network evaluated the
definitions of BPD that were commonly used for epidemiology and clinical trial outcomes for …

Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the …

PA Dargaville, COF Kamlin, F Orsini, X Wang… - Jama, 2021 - jamanetwork.com
Importance The benefits of surfactant administration via a thin catheter (minimally invasive
surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome are …

[HTML][HTML] European consensus guidelines on the management of respiratory distress syndrome–2019 update

DG Sweet, V Carnielli, G Greisen, M Hallman, E Ozek… - Neonatology, 2019 - karger.com
As management of respiratory distress syndrome (RDS) advances, clinicians must
continually revise their current practice. We report the fourth update of “European Guidelines …

European consensus guidelines on the management of respiratory distress syndrome-2016 update

DG Sweet, V Carnielli, G Greisen, M Hallman, E Ozek… - Neonatology, 2017 - karger.com
Advances in the management of respiratory distress syndrome (RDS) ensure that clinicians
must continue to revise current practice. We report the third update of the European …

[HTML][HTML] Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes

LM Davidson, SK Berkelhamer - Journal of clinical medicine, 2017 - mdpi.com
Bronchopulmonary dysplasia (BPD) is a chronic lung disease most commonly seen in
premature infants who required mechanical ventilation and oxygen therapy for acute …

[HTML][HTML] Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies

N Principi, GM Di Pietro, S Esposito - Journal of translational medicine, 2018 - Springer
Background Bronchopulmonary dysplasia (BPD) is the result of a complex process in which
several prenatal and/or postnatal factors interfere with lower respiratory tract development …

[HTML][HTML] The complex aetiology of cerebral palsy

SJ Korzeniewski, J Slaughter, M Lenski… - Nature Reviews …, 2018 - nature.com
Cerebral palsy (CP) is the most prevalent, severe and costly motor disability of childhood.
Consequently, CP is a public health priority for prevention, but its aetiology has proved …

The medicinal chemistry of caffeine

G Faudone, S Arifi, D Merk - Journal of medicinal chemistry, 2021 - ACS Publications
The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world
and has multiple beneficial pharmacological activities, for example, in neurodegenerative …